Furthermore, there were no significant differences between the two groups in sex, history of smoking or drinking, history of coronary heart disease, atrial fibrillation or stroke, use of antithrombotics and anticoagulants, Hs-CRP, FPG or blood coagulation indicators (P > 0.05). This evidence concerns the gene MAP3K14 and atrial fibrillation.